Drug Type Small molecule drug |
Synonyms T4P 1001, T4P1001 |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Chronic Pain | Phase 2 | - | - | |
| Neuralgia | Phase 2 | Belgium | - | |
| Neuralgia | Phase 2 | France | - | |
| Neuralgia, Postherpetic | Clinical | Belgium | 01 Jun 2015 | |
| Neuralgia, Postherpetic | Clinical | France | 01 Jun 2015 | |
| Osteoarthritis, Hip | Clinical | Belgium | 01 Jun 2015 | |
| Osteoarthritis, Hip | Clinical | France | 01 Jun 2015 | |
| Osteoarthritis, Knee | Clinical | Belgium | 01 Jun 2015 | |
| Osteoarthritis, Knee | Clinical | France | 01 Jun 2015 | |
| Diabetic peripheral neuropathic pain | Clinical | France | 01 Mar 2014 |
Not Applicable | 114 | Heat Pain Stimuli A+Administration of T4P1001 capsules (T4P1001) | enaudrtekz(pqzuvgxvvj) = thfessyhex zvmsucmcxl (ijiynmvelv, 1.92) View more | - | 01 Aug 2019 | ||
Heat Pain Stimuli B (Placebo) | enaudrtekz(pqzuvgxvvj) = paeezdzzje zvmsucmcxl (ijiynmvelv, 1.86) View more | ||||||
Not Applicable | 42 | (T4P1001) | inaamvmvfw(opozmqhzri) = aawgmmeate xpukvvrnqx (lclaiykbaj, 1.49) View more | - | 16 May 2016 | ||
Video B (Placebo) | inaamvmvfw(opozmqhzri) = deyjolintp xpukvvrnqx (lclaiykbaj, 1.43) View more |





